Biocept (BIOC) Reports Q2 Loss of $0.21/Share

Biocept (NASDAQ: BIOC) reported Q2 EPS of ($0.21), versus ($0.60) reported last year. Revenue for the quarter came in at $1.3 million, versus $663 thousand reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• PENN Entertainment (PENN) Reiterated at Market Outperform by Citizens as Relocation Announced
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance